Uloric (Febuxostat) Febuxostat 40mg – xanthine oxidase inhibitor for gout

Uloric is a medication containing the active ingredient febuxostat and is used in the treatment of hyperuricemia (elevated levels of uric acid in the blood) in patients with gout. Febuxostat acts by inhibiting an enzyme called xanthine oxidase, which is responsible for the production of uric acid in the body. By reducing uric acid production, Uloric helps prevent the formation of uric acid crystals in the joints, alleviating gout symptoms and preventing acute attacks. Uloric is administered orally in tablet form, and the recommended dosage is determined by the physician, taking into account the severity of hyperuricemia and the individual patient's response. It is important to follow medical instructions regarding the correct dosage, appropriate frequency of administration, and duration of treatment.